116 related articles for article (PubMed ID: 24375953)
1. Protein engineering of the antitumor enzyme PpADI for improved thermal resistance.
Zhu L; Cheng F; Piatkowski V; Schwaneberg U
Chembiochem; 2014 Jan; 15(2):276-83. PubMed ID: 24375953
[TBL] [Abstract][Full Text] [Related]
2. A potential antitumor drug (arginine deiminase) reengineered for efficient operation under physiological conditions.
Zhu L; Verma R; Roccatano D; Ni Y; Sun ZH; Schwaneberg U
Chembiochem; 2010 Nov; 11(16):2294-301. PubMed ID: 20954230
[TBL] [Abstract][Full Text] [Related]
3. Directed evolution of an antitumor drug (arginine deiminase PpADI) for increased activity at physiological pH.
Zhu L; Tee KL; Roccatano D; Sonmez B; Ni Y; Sun ZH; Schwaneberg U
Chembiochem; 2010 Mar; 11(5):691-7. PubMed ID: 20157910
[TBL] [Abstract][Full Text] [Related]
4. Rapid evolution of arginine deiminase for improved anti-tumor activity.
Ni Y; Liu Y; Schwaneberg U; Zhu L; Li N; Li L; Sun Z
Appl Microbiol Biotechnol; 2011 Apr; 90(1):193-201. PubMed ID: 21221572
[TBL] [Abstract][Full Text] [Related]
5. Directed arginine deiminase evolution for efficient inhibition of arginine-auxotrophic melanomas.
Cheng F; Zhu L; Lue H; Bernhagen J; Schwaneberg U
Appl Microbiol Biotechnol; 2015 Feb; 99(3):1237-47. PubMed ID: 25104032
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobic Mutagenesis and Semi-rational Engineering of Arginine Deiminase for Markedly Enhanced Stability and Catalytic Efficiency.
Jamil S; Liu MH; Liu YM; Han RZ; Xu GC; Ni Y
Appl Biochem Biotechnol; 2015 Jul; 176(5):1335-50. PubMed ID: 26041055
[TBL] [Abstract][Full Text] [Related]
7. Rational surface engineering of an arginine deiminase (an antitumor enzyme) for increased PEGylation efficiency.
Cheng F; Yang J; Schwaneberg U; Zhu L
Biotechnol Bioeng; 2019 Sep; 116(9):2156-2166. PubMed ID: 31062871
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of arginine deiminase activity by site-directed mutagenesis].
Li L; Ni Y; Sun Z
Sheng Wu Gong Cheng Xue Bao; 2012 Apr; 28(4):508-19. PubMed ID: 22803400
[TBL] [Abstract][Full Text] [Related]
9. Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity.
El-Sayed ASA; Shindia AA; Zeid AAA; Yassin AM; Sitohy MZ; Sitohy B
Enzyme Microb Technol; 2019 Dec; 131():109432. PubMed ID: 31615671
[TBL] [Abstract][Full Text] [Related]
10. Loop engineering reveals the importance of active-site-decorating loops and gating residue in substrate affinity modulation of arginine deiminase (an anti-tumor enzyme).
Cheng F; Yang J; Bocola M; Schwaneberg U; Zhu L
Biochem Biophys Res Commun; 2018 May; 499(2):233-238. PubMed ID: 29567479
[TBL] [Abstract][Full Text] [Related]
11. A Competitive Flow Cytometry Screening System for Directed Evolution of Therapeutic Enzyme.
Cheng F; Kardashliev T; Pitzler C; Shehzad A; Lue H; Bernhagen J; Zhu L; Schwaneberg U
ACS Synth Biol; 2015 Jul; 4(7):768-75. PubMed ID: 25658761
[TBL] [Abstract][Full Text] [Related]
12. Arginine deiminase, a potential anti-tumor drug.
Ni Y; Schwaneberg U; Sun ZH
Cancer Lett; 2008 Mar; 261(1):1-11. PubMed ID: 18179862
[TBL] [Abstract][Full Text] [Related]
13. Thermostability and Specific-Activity Enhancement of an Arginine Deiminase from Enterococcus faecalis SK23.001 via Semirational Design for l-Citrulline Production.
Cai X; Jiang H; Zhang T; Jiang B; Mu W; Miao M
J Agric Food Chem; 2018 Aug; 66(33):8841-8850. PubMed ID: 30047723
[TBL] [Abstract][Full Text] [Related]
14. PEGylation and pharmacological characterization of a potential anti-tumor drug, an engineered arginine deiminase originated from Pseudomonas plecoglossicida.
Zhang L; Liu M; Jamil S; Han R; Xu G; Ni Y
Cancer Lett; 2015 Feb; 357(1):346-354. PubMed ID: 25462857
[TBL] [Abstract][Full Text] [Related]
15. Expression of arginine deiminase from Pseudomonas plecoglossicida CGMCC2039 in Escherichia coli and its anti-tumor activity.
Ni Y; Li Z; Sun Z; Zheng P; Liu Y; Zhu L; Schwaneberg U
Curr Microbiol; 2009 Jun; 58(6):593-8. PubMed ID: 19280262
[TBL] [Abstract][Full Text] [Related]
16. Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug.
Han RZ; Xu GC; Dong JJ; Ni Y
Appl Microbiol Biotechnol; 2016 Jun; 100(11):4747-60. PubMed ID: 27087524
[TBL] [Abstract][Full Text] [Related]
17. Improving the thermostability of Geobacillus stearothermophilus xylanase XT6 by directed evolution and site-directed mutagenesis.
Zhang ZG; Yi ZL; Pei XQ; Wu ZL
Bioresour Technol; 2010 Dec; 101(23):9272-8. PubMed ID: 20691586
[TBL] [Abstract][Full Text] [Related]
18. Insights into the modulation of optimum pH by a single histidine residue in arginine deiminase from Pseudomonas aeruginosa.
Ding H; Liu H; Yin Y; Ding Y; Jia Y; Chen Q; Zou G; Zheng Z
Biol Chem; 2012 Sep; 393(9):1013-24. PubMed ID: 22944700
[TBL] [Abstract][Full Text] [Related]
19. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA
Cancer Res; 2002 Oct; 62(19):5443-50. PubMed ID: 12359751
[TBL] [Abstract][Full Text] [Related]
20. Purification, immobilization, and biochemical characterization of l-arginine deiminase from thermophilic Aspergillus fumigatus KJ434941: anticancer activity in vitro.
El-Sayed AS; Hassan MN; Nada HM
Biotechnol Prog; 2015; 31(2):396-405. PubMed ID: 25582958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
